:,

Zhihui Feng1, Biao Zhang1, Yi Liu1

  • 1Laboratory Central, Guangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541199, China.

Journal of proteomics
|November 4, 2025
PubMed
概括

这项研究确定SLC4A7,MYO9B,CPT2和棕酸是膀癌 (BC) 进展的关键因素. 这些分子可能有助于区分非肌肉侵入性和肌肉侵入性BC,提供新的治疗点.